StonvexLoading…
StonvexStonvexStonvexCore line items from ACT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $312.07M | $1.24B | $923.12M | $611.67M |
Operating Income | $213.38M | $858.84M | $635.75M | $425.92M |
Net Income | $167.77M | $674.24M | $497.08M | $333.59M |
EPS (Diluted) | $1.18 | $4.52 | $3.30 | $2.20 |
Total Assets | $6.96B | $6.89B | $6.88B | $6.77B |
Total Liabilities | $1.62B | $1.54B | $1.56B | $1.55B |
Cash & Equivalents | $549.04M | $582.49M | $543.58M | $612.97M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 140.29M | 142.21M | 145.57M | 148.38M |